Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-21
DOI
10.3389/fendo.2018.00333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibroblast growth factor 23 is induced by an activated renin–angiotensin–aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
- (2018) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene
- (2017) Xiaobin Han et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
- (2017) Alexander Grabner et al. Scientific Reports
- Differential Regulatory Role of Soluble Klothos on Cardiac Fibrogenesis in Hypertension
- (2016) Xue Liu et al. AMERICAN JOURNAL OF HYPERTENSION
- Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine
- (2016) Ioana Alesutan et al. CARDIOVASCULAR RESEARCH
- Partial Reversal of Tissue Calcification and Extension of Life Span following Ammonium Nitrate Treatment of Klotho-Deficient Mice
- (2016) Christina B. Leibrock et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Extrarenal effects of FGF23
- (2016) Dieter Haffner et al. PEDIATRIC NEPHROLOGY
- Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells
- (2016) Beatrice Richter et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction
- (2015) C. Zwadlo et al. CIRCULATION
- The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation
- (2015) Manfred Richter et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice
- (2015) Christina B. Leibrock et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency
- (2015) C. B. Leibrock et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy
- (2015) K. Yang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
- (2015) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure
- (2015) Ingrid A. Andersen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
- (2015) Peter Wohlfahrt et al. JACC-Heart Failure
- Fibroblast Growth Factor-23 and Incident Atrial Fibrillation
- (2014) Jehu S. Mathew et al. CIRCULATION
- FGF23 regulates renal sodium handling and blood pressure
- (2014) Olena Andrukhova et al. EMBO Molecular Medicine
- Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling
- (2014) M. C. Hu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate
- (2014) J. Xie et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Molecular interactions of FGF23 and PTH in phosphate regulation
- (2014) Beate Lanske et al. KIDNEY INTERNATIONAL
- Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
- (2014) Julia J. Scialla et al. Nature Reviews Nephrology
- Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism
- (2013) Ming Chang Hu et al. Annual Review of Physiology
- Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice
- (2013) Jakob Voelkl et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of vitamin D status on risk factors for cardiovascular disease
- (2013) Sujana S. Gunta et al. Nature Reviews Nephrology
- FGF-23: the rise of a novel cardiovascular risk marker in CKD
- (2012) G. H. Heine et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
- (2012) Jian Xie et al. Nature Communications
- The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
- (2011) Sarah Seiler et al. EUROPEAN HEART JOURNAL
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype
- (2010) Hua Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
- (2010) E. E. Creemers et al. CARDIOVASCULAR RESEARCH
- Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease
- (2010) Hisashi Hasegawa et al. KIDNEY INTERNATIONAL
- Hemodialysis
- (2010) Jonathan Himmelfarb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis
- (2009) M. Shawkat Razzaque Nature Reviews Endocrinology
- Endocrine functions of bone in mineral metabolism regulation
- (2008) L. Darryl Quarles JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
- NON-CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Hypertrophy and Fibrosis in the Cardiomyopathy of Uremia-Beyond Coronary Heart Disease
- (2008) Marie-Luise Gross et al. SEMINARS IN DIALYSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started